Sarepta Therapeutics (SRPT) Stock: Gaining On Positive Data

Sarepta Therapeutics SRPT Stock News

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced positive clinical data. As you could imagine, the news excited investors who are pushing the stock for the top. Today, we’ll talk about: The new data; what we’re seeing from SRPT … Read more

Sarepta Therapeutics (SRPT) Stock: Climbing Ahead Of Catalyst

Sarepta Therapeutics SRPT Stock News

Sarepta Therapeutics Inc (NASDAQ: SRPT) is climbing in the pre-market this morning. However, if you’re digging for press releases or SEC filings, you’re not going to find anything issued this morning. So, what’s the deal? Today, we’ll talk about: Why SRPT is headed up; what we’re seeing from the stock; and what we’ll be watching … Read more

Sarepta Therapeutics (SRPT) Stock: Climbing On Lifted Clinical Hold

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that the FDA has lifted a clinical hold, exciting investors who are pushing the stock for the top. Today, we’ll talk about: The lifted clinical hold; what we’re seeing from SRPT … Read more

Sarepta Therapeutics (SRPT) Stock: Soaring As Gene Therapy Shows Promise

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having an overwhelmingly strong day in the market today, and for good reason. The company announced positive preliminary results from a clinical trial assessing a gene therapy candidate. Of course, the data was positive, exciting investors and sending the stock toward the top. Today, we’ll talk about: The data; … Read more

Sarepta Therapeutics (SRPT) Stock: Headed For The Top On Expanded Partnership

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having an overwhelmingly strong start to the trading session this morning after announcing an expanded partnership. The partnership surrounds the mutual goal of companies involved to assist clinicians in identifying patients with Duchenne muscular dystrophy (DMD). Of course, the news excited investors, sending the stock on a run for … Read more

Sarepta Therapeutics (SRPT) Stock: Soaring On Clinical Results

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having an incredibly strong start to the trading session in the pre-market hours this morning, and for good reason. The company released results from a key clinical trial surrounding DMD. With the positive results in mind, excited investors sent the value of the stock soaring. Of course, our partners … Read more

Sarepta Therapeutics (SRPT) Stock: Gains On Strong Revenue | CEO Stepping Down

Sarepta Therapeutics Inc (NASDAQ: SRPT) is off to an incredible start in the pre-market hours this morning, and for good reason. The company reported earnings, missing on earnings per share, but beating on revenue. Also, the company informed investors that the CEO would be stepping down. Of course, our partners at Trade Ideas were the … Read more

Sarepta Therapeutics (SRPT) Stock: Gains On Coming FDA Advisory Committee Meeting

Sarepta Therapeutics Inc (NASDAQ: SRPT) is having a strong day in the market today after the FDA announced a forthcoming Pediatric Advisory Committee meeting. The meeting led to excitement among investors and sent the stock upward. As is nearly always the case, our partners at Trade Ideas were the first to alert us to the … Read more